{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2018-N-2727\" and posted_year = 2024 sorted by posted_date descending", "rows": [["FDA-2018-N-2727-0075", "FDA", "FDA-2018-N-2727", "Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Institutional Review Board Waiver or Alteration of Informed Consent for Minimal Risk Clinical Investigations", "Notice", "Announcement", "2024-01-18T05:00:00Z", 2024, 1, "2024-01-18T05:00:00Z", null, "2024-01-18T13:44:49Z", "2024-00886", 0, 0, "09000064863a76e8"], ["FDA-2018-N-2727-0066", "FDA", "FDA-2018-N-2727", "15 SACHRP (2017) Recommendations on the Expedited Review List", "Supporting & Related Material", "Background Material", "2024-01-10T05:00:00Z", 2024, 1, null, null, "2024-01-10T16:54:47Z", null, 0, 0, "090000648634e019"], ["FDA-2018-N-2727-0065", "FDA", "FDA-2018-N-2727", "14 FDA (1998) Protection of Human Subjects Categories of Research That May Be Reviewed by the Institutional Review Board (IRB) Through an Expedited Review Procedure", "Supporting & Related Material", "Background Material", "2024-01-10T05:00:00Z", 2024, 1, null, null, "2024-01-10T16:54:32Z", null, 0, 0, "090000648634e018"], ["FDA-2018-N-2727-0067", "FDA", "FDA-2018-N-2727", "16 OHRP (2021) Revised Common Rule Q&As", "Supporting & Related Material", "Background Material", "2024-01-10T05:00:00Z", 2024, 1, null, null, "2024-01-10T16:54:52Z", null, 0, 0, "090000648634e639"], ["FDA-2018-N-2727-0062", "FDA", "FDA-2018-N-2727", "11WMA (2022) Declaration of Helsinki--Ethical Principles for Medical Research Involving Human Subjects", "Supporting & Related Material", "Background Material", "2024-01-10T05:00:00Z", 2024, 1, null, null, "2024-01-10T16:54:05Z", null, 0, 0, "090000648634e015"], ["FDA-2018-N-2727-0064", "FDA", "FDA-2018-N-2727", "13 FDA (2010) Guidance for Industry and FDA Staff In Vitro Diagnostic (IVD) Device Studies--Frequently Asked Questions", "Supporting & Related Material", "Background Material", "2024-01-10T05:00:00Z", 2024, 1, null, null, "2024-01-10T16:54:24Z", null, 0, 0, "090000648634e017"], ["FDA-2018-N-2727-0070", "FDA", "FDA-2018-N-2727", "TAB A - IRB Waiver RIA as Submitted to OMB", "Supporting & Related Material", "Background Material", "2024-01-10T05:00:00Z", 2024, 1, null, null, "2024-01-10T16:56:09Z", null, 0, 0, "090000648638fd1f"], ["FDA-2018-N-2727-0069", "FDA", "FDA-2018-N-2727", "TAB A - IRB Waiver Final Rule as Submitted to OMB", "Supporting & Related Material", "Background Material", "2024-01-10T05:00:00Z", 2024, 1, null, null, "2024-01-10T16:55:56Z", null, 0, 0, "090000648638f8a8"], ["FDA-2018-N-2727-0071", "FDA", "FDA-2018-N-2727", "TAB B - IRB Waiver Final Rule Track Changes", "Supporting & Related Material", "Background Material", "2024-01-10T05:00:00Z", 2024, 1, null, null, "2024-01-10T16:56:32Z", null, 0, 0, "090000648638fd20"], ["FDA-2018-N-2727-0068", "FDA", "FDA-2018-N-2727", "Memorandum to FDA DMS on IRB Waiver FR (FDA-2018-N-2727)", "Supporting & Related Material", "Background Material", "2024-01-10T05:00:00Z", 2024, 1, null, null, "2024-01-10T16:55:33Z", null, 0, 0, "090000648638f8a5"], ["FDA-2018-N-2727-0059", "FDA", "FDA-2018-N-2727", "8 FDA and OHRP (2018) Institutional Review Board (IRB) Written Procedures Guidance for Institutions and IRBs", "Supporting & Related Material", "Background Material", "2024-01-10T05:00:00Z", 2024, 1, null, null, "2024-01-10T16:53:47Z", null, 0, 0, "090000648634e012"], ["FDA-2018-N-2727-0063", "FDA", "FDA-2018-N-2727", "12 FDA (2006) Guidance on Informed Consent for In Vitro Diagnostic Device Studies Using Leftover Human Specimens that are Not Individually Identifiable", "Supporting & Related Material", "Background Material", "2024-01-10T05:00:00Z", 2024, 1, null, null, "2024-01-10T16:54:17Z", null, 0, 0, "090000648634e016"], ["FDA-2018-N-2727-0060", "FDA", "FDA-2018-N-2727", "9 FDA (2006) Information Sheet Guidance for IRBs Clinical Investigators and Sponsors Significant Risk and Nonsignificant Risk Medical Device Studies", "Supporting & Related Material", "Background Material", "2024-01-10T05:00:00Z", 2024, 1, null, null, "2024-01-10T16:53:54Z", null, 0, 0, "090000648634e013"], ["FDA-2018-N-2727-0052", "FDA", "FDA-2018-N-2727", "1 US Dept of State (2011) Fourth Periodic Report of the United States of America to the United Nations Committee on Human Rights Concerning the ICCPR", "Supporting & Related Material", "Background Material", "2024-01-10T05:00:00Z", 2024, 1, null, null, "2024-01-10T16:52:48Z", null, 0, 0, "090000648634e5ef"], ["FDA-2018-N-2727-0058", "FDA", "FDA-2018-N-2727", "7 Kraft et al. (2017)Research on Medical Practices Why Patients Consider Participating and the Investigational Misconception", "Supporting & Related Material", "Background Material", "2024-01-10T05:00:00Z", 2024, 1, null, null, "2024-01-10T16:53:34Z", null, 0, 0, "090000648634e011"], ["FDA-2018-N-2727-0073", "FDA", "FDA-2018-N-2727", "TAB C - IRB Waiver Final Rule as Cleared by OMB", "Supporting & Related Material", "Background Material", "2024-01-10T05:00:00Z", 2024, 1, null, null, "2024-01-10T16:57:08Z", null, 0, 0, "090000648638fd24"], ["FDA-2018-N-2727-0053", "FDA", "FDA-2018-N-2727", "2 SACHRP (2008) Recommendations Related to Waiver of Informed Consent and Interpretation of Minimal Risk", "Supporting & Related Material", "Background Material", "2024-01-10T05:00:00Z", 2024, 1, null, null, "2024-01-10T16:52:56Z", null, 0, 0, "090000648634e5f0"], ["FDA-2018-N-2727-0055", "FDA", "FDA-2018-N-2727", "4 Baker and Merz (2018) What Gives Them the Right Legal Privilege and Waivers of Consent for Research", "Supporting & Related Material", "Background Material", "2024-01-10T05:00:00Z", 2024, 1, null, null, "2024-01-10T16:53:05Z", null, 0, 0, "090000648634e5f2"], ["FDA-2018-N-2727-0061", "FDA", "FDA-2018-N-2727", "10 CIOMS (2016) International Ethical Guidelines for Health-related Research Involving Humans", "Supporting & Related Material", "Background Material", "2024-01-10T05:00:00Z", 2024, 1, null, null, "2024-01-10T16:53:58Z", null, 0, 0, "090000648634e014"], ["FDA-2018-N-2727-0057", "FDA", "FDA-2018-N-2727", "6 Kripalani et al. (2021) Disparities in Research Participation by Level of Health Literacy", "Supporting & Related Material", "Background Material", "2024-01-10T05:00:00Z", 2024, 1, null, null, "2024-01-10T16:53:25Z", null, 0, 0, "090000648634e010"], ["FDA-2018-N-2727-0056", "FDA", "FDA-2018-N-2727", "5 van Zon et al. (2016) Active Recruitment and Limited Participant-load Related to High Participation in Large Population-based Biobank Studies", "Supporting & Related Material", "Background Material", "2024-01-10T05:00:00Z", 2024, 1, null, null, "2024-01-10T16:53:13Z", null, 0, 0, "090000648634e5f3"], ["FDA-2018-N-2727-0072", "FDA", "FDA-2018-N-2727", "TAB B - IRB Waiver RIA Track Changes", "Supporting & Related Material", "Background Material", "2024-01-10T05:00:00Z", 2024, 1, null, null, "2024-01-10T16:56:50Z", null, 0, 0, "090000648638fd21"], ["FDA-2018-N-2727-0074", "FDA", "FDA-2018-N-2727", "TAB C - IRB Waiver RIA as Cleared by OMB", "Supporting & Related Material", "Background Material", "2024-01-10T05:00:00Z", 2024, 1, null, null, "2024-01-10T16:57:31Z", null, 0, 0, "090000648638fd25"], ["FDA-2018-N-2727-0054", "FDA", "FDA-2018-N-2727", "3 EoP (1997) Strengthened Protections for Human Subject of Classified Research", "Supporting & Related Material", "Background Material", "2024-01-10T05:00:00Z", 2024, 1, null, null, "2024-01-10T16:53:01Z", null, 0, 0, "090000648634e5f1"]], "truncated": false, "filtered_table_rows_count": 24, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 and \"posted_year\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA-2018-N-2727", "p1": "2024"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2018-N-2727&posted_year=2024", "results": [{"value": "FDA", "label": "FDA", "count": 24, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-2727&posted_year=2024&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2018-N-2727&posted_year=2024", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 23, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-2727&posted_year=2024&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Notice", "label": "Notice", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-2727&posted_year=2024&document_type=Notice", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2018-N-2727&posted_year=2024", "results": [{"value": 2024, "label": 2024, "count": 24, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-2727", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-2727&posted_year=2024&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-2727&posted_year=2024&_facet=posted_date"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-2727&posted_year=2024&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-2727&posted_year=2024&_facet_date=comment_start_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-2727&posted_year=2024&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 1110.5206480715424, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}